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Abstract
Background—Practice variation in breast cancer surgery has raised concerns about the quality
of treatment decisions. We sought to evaluate the quality of decisions about surgery for early stage
breast cancer by measuring patient knowledge, concordance between goals and treatments, and
involvement in decisions.
Study Design—A mailed survey of Stage I/II breast cancer survivors was conducted at four
sites. The Decision Quality Instrument measured knowledge, goals, and involvement in decisions.
A multivariable logistic regression model of treatment was developed. The model-predicted
probability of mastectomy was compared to treatment received for each patient. Concordance was
defined as having mastectomy and predicted probability >=0.5 or partial mastectomy and
predicted probability <0.5. Frequency of discussion about partial mastectomy was compared to
discussion about mastectomy using chi-squared tests.
Results—440 patients participated (59% response rate). Mean overall knowledge was 52.7%.
45.9% knew that local recurrence risk is higher after breast conservation. 55.7% knew that
survival is equivalent for the two options. Most participants (89.0%) had treatment concordant
with their goals. Participants preferring mastectomy had lower concordance (80.5%) than those
preferring partial mastectomy (92.6%, p=0.001). Participants reported more frequent discussion of
partial mastectomy and its advantages than of mastectomy. 48.6% reported being asked their
preference.
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Conclusions—Breast cancer survivors had major knowledge deficits, and those preferring
mastectomy were less likely to have treatment concordant with goals. Patients perceived that
discussions focused on partial mastectomy, and many were not asked their preference.
Improvements in the quality of decisions about breast cancer surgery are needed.
Introduction
Geographic variation in rates of mastectomy and breast conserving surgery1,2 has led to
concerns about the quality of decisions about surgical treatment for early stage breast
cancer.3 Even since the dissemination of recommendations in favor of breast conservation
therapy in the early 1990s, rates of mastectomy and partial mastectomy have varied by
region, age, and race.4-6 The decision about type of surgery for early stage breast cancer is
considered a “preference-sensitive decision” for patients who are clinically eligible for either
option, because the best choice depends primarily on the patient's preferences.7 For
preference-sensitive decisions, an international consensus process has defined decision
quality as the degree to which a decision is informed and concordant with patient
preferences.8, 9
The quality of decisions about surgical treatment for early stage breast cancer in the United
States is unclear. Breast cancer patients have reported unfulfilled information needs10 and
shown significant deficits in knowledge about treatments.11-13 Studies of patient knowledge
have been limited by a lack of validated knowledge measures specific to the breast cancer
surgery decision12, 14 and a failure to consider specific treatment attributes besides
recurrence and survival.11, 15-18 Validated and specific measures of preference concordance
are also lacking.19, 20 Although several studies have reported on which patient concerns
affect decisions about surgery for breast cancer, 21-23 few have attempted to quantify the
degree to which treatments reflect patient preferences.24
The purpose of this study was to evaluate the quality of decisions about surgery for early
stage breast cancer. We specifically sought to measure patient knowledge about surgical
options and to evaluate the degree to which treatments were concordant with patient
preferences and goals. Secondary objectives were to identify factors associated with
knowledge and to describe patient involvement in the decision making process.
Methods
Study design
We conducted a cross-sectional mailed survey of recent breast cancer survivors at four
academic medical centers from October 2008 to February 2011. The institutional review
board at each institution approved the study.
Patient Population
Subjects included a sample of adult women with a history of early-stage invasive breast
cancer (Stages I, II) diagnosed one to three years prior to contact (2005 to 2010) and treated
at one of four institutions (Dana-Farber Cancer Institute, Massachusetts General Hospital,
University of California San Francisco, and University of North Carolina at Chapel Hill).
We excluded patients who had Stage III or IV disease, DCIS only, bilateral breast cancer, or
neoadjuvant chemotherapy, and those who could not speak and read English.
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Study Design and Procedures
Eligible patients were identified through each site's cancer registry. Permission to contact
and confirmation of eligibility to participate were requested from each patient's provider. A
modified Dillman survey method was followed.25 Patients were mailed an introductory
letter, survey instrument, consent forms, opt-out card, and packet of breast cancer awareness
postage stamps (worth approximately $5). After two weeks, study staff members called
patients who had not opted out, to discuss the study, answer questions, and encourage survey
completion. After another two weeks, a reminder packet was mailed to non-responders.
Participants received a thank you note with another packet of postage stamps. Each
participant provided written informed consent.
Measures
The survey contained questions about demographics, clinical history, preferred treatment,
perception of being informed, and the Decision Quality Instrument. Demographic, medical,
and treatment data were obtained from the cancer registry. When a patient's report conflicted
with the registry on a clinical issue (e.g. stage), the medical record was examined.
Breast Cancer Surgery Decision Quality Instrument (BCS-DQI)—The BCS-DQI
contains items that cover three domains – knowledge, goals and concerns, and involvement
in decisions. (See appendix 1). The domains were based on a consensus of clinicians,
consumers, and medical decision making experts, which defined decision quality as the
degree to which the patient is informed, meaningfully involved in decision making, and
receiving care that matches her goals.8 The instrument has demonstrated feasibility of
administration, acceptability to patients, discriminant validity, content validity (based on
provider and patient reports), and strong retest reliability (intraclass correlation coefficient
of 0.81) in this sample.26 The instrument refers to partial mastectomy as “lumpectomy” to
be more comprehensible to patients.
1. Knowledge. 12 multiple choice or fill-in-the-blank items about breast cancer and
the local treatment options including local recurrence, survival, and side effects.
2. Goals and concerns. 6 items rated on a scale from 0 (not at all important) to 10
(extremely important).
3. Involvement. 7 multiple choice items about the content of discussions with
providers and how involved the patient was in decision making.
Preferred treatment—Single item: “Which option was your personal preference?” with
responses “Lumpectomy only”, “Lumpectomy with radiation”, “Mastectomy”, or “I am not
sure”.
Treatment received—This was defined as the final treatment received, according to the
cancer registry (and the chart, if the patient's report conflicted with the registry). In patients
who had partial mastectomy followed by mastectomy, treatment received was defined as
mastectomy.
Perception of being informed—Single item: “On a scale from 0 to 10, where 10 means
extremely well informed and 0 means not informed at all, how informed did you feel about
surgical options for breast cancer?”
Statistical Analysis
Knowledge—The number of correct knowledge items was divided by the total number of
knowledge items and multiplied by 100, resulting in a knowledge score from 0% to 100%
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for each patient. Quantitative, fill-in-the-blank items were considered correct if they fell
within a range determined a priori by medical experts based on clinical evidence. An “I am
not sure” response was considered incorrect, and missing responses were imputed with 1/k,
where k was the number of possible responses. Knowledge scores were calculated for every
respondent who completed at least 6 of 12 items.
Chi-square tests were used to compare the percentage of partial mastectomy patients with
correct answers to the percentage of mastectomy patients with correct answers, for each
question. A two-sample t-test was used to compare the mean knowledge scores between
groups.
To identify characteristics associated with higher knowledge, univariate analysis with a two-
sample t-test or analysis of variance was performed. A multivariable linear regression model
was created, including variables significant at the 0.05 level from univariate analysis.
Association between perception of being informed and actual overall knowledge was
summarized using Pearson's correlation coefficient.
Concordance score—To estimate the extent to which treatment received was associated
with a patient's goals, we used the following approach, which has been described
previously. 27 A multivariable logistic regression model of treatment (partial mastectomy
versus mastectomy) was developed, including stage and the six goals and concerns as
candidate predictors. Goals and concerns were included based on the premise that preference
sensitive decisions should incorporate the personal goals and concerns of the patient. Stage
was included in the model to account for clinical appropriateness. Missing responses about
goals were imputed from other available goal items.28 The final concordance model
included stage and those goals and concerns that were significant at the 0.05 level on
multivariate analysis. The model-predicted probability of mastectomy was then calculated
for each patient based on the logistic regression model estimates. Patients with a predicted
probability >=0.5 who had mastectomy and those with a predicted probability <0.5 who had
partial mastectomy were classified as having concordant care. The proportion of patients
with concordant care was calculated for the sample. For these analyses, we excluded patients
who had partial mastectomy followed by mastectomy.
Involvement—The frequency of discussion about partial mastectomy and its pros and cons




We identified 769 potential participants, of whom providers excluded 23 (3.0%) as
ineligible or unable to fully participate. Of the remaining 746 patients, 440 (59%) responded
(Table 1). Respondents were more likely to be white than non-responders (85.2% vs. 71.4%,
p<0.0001). Most respondents (N=272, 61.8%) had undergone partial mastectomy; 111
respondents (25.2%) had undergone initial mastectomy, and 57 respondents (13.0%) had
undergone partial mastectomy followed by mastectomy (primarily to obtain negative
margins). The 57 patients who had undergone partial mastectomy followed by mastectomy
were classified as having undergone mastectomy.
Knowledge
Overall, participants' mean knowledge score was 52.7% (SD 21.8%) (Table 2). Fifty-eight
percent of participants scored 50% or higher.
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Local recurrence—About half of participants (45.9%) knew that the risk of local
recurrence is higher after partial mastectomy with radiation than after mastectomy. The
remaining participants answered “there is no difference” (28.2%) or “I am not sure”
(24.5%). Participants who had partial mastectomy were less likely to answer this question
correctly (p<0.0001).
A minority of participants could accurately estimate the 10 year risk of local recurrence after
either surgical option. For the risk of local recurrence after partial mastectomy and radiation,
36.8% responded correctly (5 to 15% was considered correct). Incorrect responses were
mostly overestimations (18.6%), and women who had partial mastectomy were more likely
to answer correctly (p=0.016). For the risk of local recurrence after mastectomy, 37.5%
responded correctly (2 to 10% was considered correct). Incorrect responses were split
between under (14.8%) and over (14.6%) estimations. Frequency of correct responses did
not vary by treatment. For both questions, approximately one-third responded “I am not
sure”.
Survival—About half of participants (55.7%) knew that partial mastectomy with radiation
and mastectomy resulted in equivalent survival, and 29.3% responded “I am not sure”.
Participants who had undergone partial mastectomy were more likely to answer this
question correctly (p<0.0001).
Specifics of breast conservation therapy—Most (69.1%) knew that partial
mastectomy was more likely to require reoperation for margins. A minority knew how many
women who have partial mastectomy and radiation are very satisfied with appearance of the
breast, with 28.4% correctly responding “most”, 32.5% responding “some” or “a few”, 5.0%
responding “none”, and 32.1% responding “I am not sure”. Participants who had partial
mastectomy were more likely to answer this question correctly. A minority knew the
approximate prevalence of serious radiation side effects, with 26.8% correctly responding
“fewer than 5%”, 8.4% responding “5-10%”, 4.3% responding “10% or higher”, and 58.4%
responding “I am not sure”. Women who had partial mastectomy were more likely to answer
this question correctly.
On multivariable analysis, younger age, white race, higher education, higher income, lower
stage of disease, treatment with partial mastectomy, and more recent diagnosis were
associated with higher knowledge (Table 3). Overall, participants felt they were well-
informed (mean 8.7 out of 10, SD 1.7), but the perception of being informed did not
correlate with their overall knowledge score (Pearson's coefficient 0.08, p=0.10).
Knowledge scores did not vary significantly by site (Table 3).
Concordance between goals and treatment
Receipt of mastectomy was associated with three of the goals/concerns on multivariable
analysis (Table 4). The goals “remove your breast for peace of mind” and “avoid radiation”
were positively associated with mastectomy, while the goal “keep your breast” was
negatively associated with mastectomy. The overall concordance score, or percentage of
patients who got the treatment predicted by the model, was 89.0%. Concordance was lower
for mastectomy than for partial mastectomy. Specifically, women for whom the model
predicted mastectomy received mastectomy 80.5% of the time, whereas women for whom
the model predicted partial mastectomy received partial mastectomy 92.6% of the time
(p=0.001). Treatment choice did not vary significantly by site (Table 3).
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Involvement in decision making
Most participants (90.0%) reported that their providers discussed partial mastectomy as an
option (Table 5). Fewer (68.0%) reported a discussion of mastectomy as an option
(p<0.0001), and 58.6% reported a discussion of both options. More participants reported
discussion about the reasons for partial mastectomy (75.5%) than discussion of the reasons
for mastectomy (53.9%, p<0.0001). Conversely, fewer participants reported discussion of
the reasons against partial mastectomy (36.1%) than discussion of reasons against
mastectomy (49.3%, p=0.0002). Most participants reported that the provider made a
treatment recommendation (83.2%). Less than half (48.6%) reported that their provider
asked their treatment preference.
Discussion
For breast surgery, the quality of decisions can be judged by the extent to which patients are
informed, involved in decision making, and undergoing treatments that reflect their goals.
This study is the first to fully describe the quality of breast cancer surgery decisions along
these three dimensions. In general, participants had significant deficits in knowledge one to
three years after diagnosis, including knowledge about local recurrence and survival. Their
reports of discussions with providers suggested that patients were not always meaningfully
involved in selecting treatments. Most participants had treatment that was concordant with
their goals, but women who preferred mastectomy were less likely to have concordance than
women who preferred partial mastectomy.
Patients in this sample lacked knowledge regarding approximately half of the information
that providers had identified as critical. Although we would expect patients to have forgotten
some information since surgery (particularly the specific risk estimates), even the gist or
summary information questions showed large knowledge gaps. For example, only half of the
sampled patients knew that survival was the same for breast conservation therapy and
mastectomy. Women who had partial mastectomy were less knowledgeable about local
recurrence than women who had mastectomy, despite being equally concerned about it. We
found this somewhat concerning, since patients who opt for partial mastectomy need to be
aware of their slightly higher risk of local recurrence.
Our findings regarding knowledge about recurrence and survival are similar to other reports.
In one population-based study (limited to Detroit and LA), 26% of breast cancer survivors
knew that local recurrence was higher after breast conservation therapy, and 48% knew that
survival was equivalent for breast conservation therapy and mastectomy.11 At one academic
center, 45% of survivors knew that local recurrence was higher after breast conservation
therapy, and 53% knew about the survival equivalence.29 Our study confirms these findings,
using a tested and validated knowledge measure.
Concordance between treatments and goals was relatively high, but a substantial minority of
participants (18%) received treatment they did not prefer, and women who preferred
mastectomy were more likely to receive discordant care. Some of this discordance may be
related to providers' beliefs in the advantages of breast conservation therapy. Patient reports
on the interaction revealed that one-third of participants could not recall ever being
presented with the option of mastectomy. About half of respondents reported that they were
not asked for their treatment preference. In fact, they recalled providers making a
recommendation twice as often as asking for patients' preferences. Some of the patients who
had mastectomy may have had contraindications to breast conservation (e.g., tumor size
relative to breast size, prior chest radiation). We attempted to minimize this possibility by
having providers confirm eligibility, including stage in the treatment model, and excluding
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patients who had partial mastectomy followed by mastectomy from the concordance
analysis.
Women who prefer mastectomy may be lacking support from some providers and requiring
greater effort to obtain the treatments they prefer. Breast surgeons tend to prefer breast
conservation therapy to mastectomy,30 and they report frequent conflicts with patients who
are eligible for breast conservation but want mastectomy.31 A growing body of research is
finding that some women who are highly informed and have no clinical contraindication to
breast conservation still prefer mastectomy.24,32 In addition, greater involvement in the
decision making process has been associated with choice of mastectomy.32, 33
The retrospective design of this study has important limitations. Participants may have
forgotten information, so knowledge at the time of decisions may have been higher than
what we measured. In addition, participants' reports of their goals and concerns may have
been affected by recall bias, in which a person's experiences after an event influence her
memories and perceptions of that event. For example, a patient who chose breast
conservation therapy and then experienced substantial anxiety with each surveillance
mammogram may have been more likely to report a high level of concern about recurrence
than she actually had at the time of decision making. A prospective study measuring
decision quality closer to the time of decisions would shed light on the direction and
magnitude of these potential biases.
Recall bias could also affect participants' report of their interaction with providers, with
patients tending to have more memory of discussions about the treatments they received.
Evaluating this would be possible through comparison of patient report to documentation in
the medical record or to audio-recordings of the clinical encounter. Such approaches could
provide insight into these processes in the future.
The study population had relatively high proportions of white, younger, educated, and
higher-income patients. The sample came exclusively from academic medical centers and
included English-speaking women only. We are uncertain how other populations would
differ, in terms of patient goals and treatments received. Since our population had relatively
good access to health care, we hypothesize that other more vulnerable populations may have
larger knowledge deficits and lower concordance. Some variation in patient knowledge and
preferences by site may have existed, despite our attempts to achieve uniformity by using
the same eligibility criteria, enrollment approaches, and data collection methods across sites.
We did not find differences in knowledge or treatment by site, but the sample size was not
large enough to detect small differences. Future studies should seek to replicate or
disconfirm our findings in more diverse settings and with more diverse populations.
Making improvements in the quality of breast cancer surgical decisions will require
interventions to enhance patient knowledge and promote incorporation of preferences into
treatment decisions. Decision aids are tools designed to inform patients about key facts, help
them clarify preferences, and prepare them for interaction with providers. They have proven
effective at improving knowledge, reducing decisional conflict, and increasing participation
in decisions.34 Specific decision aids for breast cancer surgery have demonstrated
improvements in knowledge about recurrence and survival.12, 14 Communication aids, such
as question lists and consultation audio-recordings, increase question-asking and
information recall, respectively.35, 36 Integration of decision and communication aids into
the routine delivery of breast cancer care has been successful at some centers.24, 37, 38
In conclusion, our study demonstrated that early stage breast cancer survivors had deficits in
breast cancer knowledge, and those who preferred mastectomy were less likely to receive
treatment that was concordant with their preferences. Patients recalled the discussion of
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surgical options as tending to focus on breast conservation therapy and its advantages, and
many patients reported they were not asked for their treatment preference. Overall,
improvements in the quality of decisions about surgery for early stage breast cancer are
needed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 3
Univariate (Two-Sample t-test or Analysis of Variance) and Multivariable (Linear
Regression) Analyses of Factors Associated with Knowledge
Multivariable
Characteristic Mean knowledge (% correct) Univariate p value Regression coefficient p Value
Age at diagnosis, y
 < 50 59.1 <0.0001 10.9 <0.0001
 >=50* 48.5
Race
 White 54.6 0.0001 8.4 0.001
 Non-white* 43.1
Education
 < College graduate 46.3 <0.0001 -6.3 0.002
 > = College graduate* 56.3
Annual income
 < $60,000 43.9 <0.0001 -6.7 0.003
 >= $60,000* 57.0
Marital status
 Partnered 54.8 0.004 2.9 0.18
 Single/divorced/widowed* 48.1
Stage
 I 55.2 0.002 4.5 0.02
 II* 48.8
Surgical treatment








 < 24 56.4 0.02 5.1 0.01
 >= 24* 51.1
*
Referent group.
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Table 5
Involvement in Decision Making (n=440)
Question about involvement n %* 95% CI
Did any of your doctors discuss mastectomy as an option for you?
 Yes 299 68.0 63.4, 72.3
 No / I'm not sure 139 31.6 27.3, 36.2
Did any of your doctors discuss lumpectomy and radiation as an option for you?
 Yes 396 90.0 86.8, 92.6
 No / I'm not sure 43 9.8 7.2, 12.9
How much did your doctors discuss reasons to have mastectomy with you?
 A lot/Some 237 53.9 49.1, 58.6
 A little/Not at all 176 40.0 35.4, 44.7
 I am not sure 13 3.0 1.6, 5.0
How much did doctors discuss reasons not to have mastectomy with you?
 A lot/Some 217 49.3 44.6, 54.1
 A little/Not at all 195 44.3 39.6, 49.1
 I am not sure 18 4.1 2.4, 6.4
How much did doctors discuss reasons to have lumpectomy and radiation with you?
 A lot/Some 332 75.5 71.2, 79.4
 A little/Not at all 92 20.9 17.2, 25.0
 I am not sure 6 1.4 0.5, 2.9
How much did doctors discuss reasons not to have lumpectomy and radiation with you?
 A lot/Some 159 36.1 31.6, 40.8
 A little/Not at all 254 57.7 53.0, 62.4
 I am not sure 14 3.2 1.8, 5.3
Did any of your doctors ask you whether you preferred lumpectomy or mastectomy?
 Yes 214 48.6 43.9, 53.4
 No 184 41.8 37.2, 46.6
 I am not sure 36 8.2 5.8, 11.1
Some questions have been reworded to fit this table.
*
Not all responses add to 100% due to missing data.
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